APRE - Aprea Therapeutics, Inc.

APRE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gilad Oren	393.9K	-	-
Dir	Duey Marc	259.3K	-	-
Dir	Seizinger Bernd R.	48.9K	-	-
CFO	Hamill John P.	43.5K	-	-
Dir	Henneman John B III	13.4K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 14, 2024	Gilad Oren	President/ CEO	Buy	1,150	$2.58	$2,971.00	+0.3%	+33.6%	-41.0%
Oct 11, 2024	Seizinger Bernd R.54	Director	Buy	10,000	$2.68	$26,800.00	+28.8%	+40.6%	-45.4%
Oct 11, 2024	Hamill John P.	Srvp/ Cfo/ Prin Fin &Acct Officer	Buy	50	$2.46	$123.19	+0.3%	+40.6%	-45.4%
Oct 10, 2024	Hamill John P.	Srvp/ Cfo/ Prin Fin &Acct Officer	Buy	450	$2.61	$1,174.50	+2.4%	+55.1%	-44.1%
Mar 13, 2024	Gilad Oren	President, CEO	Buy	2,000	$7.29	$14,580.00	+0.6%	-19.6%	-57.2%
Mar 13, 2024	Henneman John B III	Director	Buy	6,860	$7.29	$50,009.40	+536.4%	-19.6%	-57.2%
Mar 13, 2024	Seizinger Bernd R.54	Director	Buy	6,860	$7.29	$50,009.40	+25.6%	-19.6%	-57.2%
Mar 13, 2024	Hamill John P.	Srvp/ Cfo/ Prin Fin &Acct Officer	Buy	1,010	$7.29	$7,362.90	+7.0%	-19.6%	-57.2%
Jun 7, 2023	Seizinger Bernd R.54	Director	Buy	10,097	$3.66	$36,956.55	+62.2%	+9.0%	+32.5%
May 18, 2022	Schade Christian S	Chairman &CEO	Buy	37,500	$0.64	$24,123.75	+14.7%	+40.8%	-70.1%